Phase i study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

Hitoshi Kusaba, Taito Esaki, Junji Kishimoto, Keita Uchino, Shuji Arita, Hozumi Kumagai, Kenji Mitsugi, Koichi Akashi, Eishi Baba

研究成果: Contribution to journalReview article

1 引用 (Scopus)

フィンガープリント Phase i study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

Medicine & Life Sciences

Chemical Compounds